3-methylcholanthrene has been researched along with spermine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekrami, H; Kennedy, AR; Shen, WC; Witschi, H | 1 |
| Kennedy, AR; Kritchevsky, D; Shen, WC | 1 |
2 other study(ies) available for 3-methylcholanthrene and spermine
| Article | Year |
|---|---|
Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent.
Topics: Animals; Anticarcinogenic Agents; Body Weight; Cell Survival; Chromatography, Gel; Chymotrypsin; Injections, Intravenous; Lung Neoplasms; Male; Methylcholanthrene; Mice; Mice, Inbred A; Mice, Inbred BALB C; Polylysine; Spermine; Tissue Distribution; Trypsin Inhibitor, Bowman-Birk Soybean; Tumor Cells, Cultured | 1993 |
Effects of spermine-conjugated Bowman-Birk inhibitor (spermine-BBI) on carcinogenesis and cholesterol biosynthesis in mice.
Topics: Animals; Anticarcinogenic Agents; Anticholesteremic Agents; Carcinogens; Cholesterol; Heart Diseases; Injections, Intraperitoneal; Liver; Lung Neoplasms; Male; Methylcholanthrene; Mice; Mice, Inbred A; Spermine; Trypsin Inhibitor, Bowman-Birk Soybean | 2003 |